WPL06521 - Managed Service for Orthotics
In plain English
The notice doesn't say
The notice as published
This is an Intention to Award Notice published pursuant to Regulation 9(3) and 9(4) and Schedule 3 of the Health Care Services (Provider Selection Regime) Regulations 2023 to award a new contract to the incumbent provider, following Direct Award Process C, and for the avoidance of doubt, the Public Contracts Regulations 2015 (and Procurement Act 2023) do not apply. University Hospital Southampton NHS Foundation Trust (UHS) intends to award a new contract directly to Peacocks Medical Group Ltd for the managed service for orthotics. The managed service for orthotics contract provides an integrated, end-to-end clinical orthotic service at Southampton General Hospital, Royal South Hants Hospital and from the supplier's own off site location. Scope of delivery includes, specialist orthotic clinical staffing and consultation, acute inpatient ward support and urgent care therapies, scheduled outpatient clinic operations, design, custom manufacturing, and supply of orthotic appliances and full inventory and supply chain management for Orthoses. University Hospital Southampton NHS Foundation Trust (UHS) intends to award an interim contract to Peacocks Medical Group Limited for the delivery of a comprehensive Managed Service for Orthotics across UHS hospital sites (including Southampton General Hospital and Royal South Hants Hospital). The service encompasses: Provision of HCPC-registered Orthotists to deliver specialist outpatient orthotic clinics and inpatient ward consultations across acute, paediatric, neuro-rehabilitation, diabetic foot, trauma, and musculoskeletal pathways; Full clinical assessment, biomechanical gait analysis, casting/scanning, prescription, manufacture, supply, fitting, adjustment, and ongoing clinical review of custom-made (bespoke) and stock orthotic devices; Operation of on-site workshop/modification facilities, stock inventory management, clinical governance, and compliance with Medical Devices Regulations (UK MDR 2002) and MHRA standards. The contract is awarded for a fixed interim term of 10 months from 1 December 2026 to 30 September 2027 with an optional 6 month extension, This is to enable completion of a review of the scope of the orthotic service in the region with the ICB so acts as bridging arrangement to provide continuity in the meantime. The approximate lifetime contract value (including the optional extension) is £2,720,000 (excluding VAT). This contract is being awarded under Direct Award Process C of the Health Care Services (Provider Selection Regime) Regulations 2023 on the following grounds: The existing contract is due to expire, and the proposed new contract is for the same core clinical orthotic service without considerable change to the nature of the services or the commercial terms. Based on a thorough clinically audited and documented review of the contract performance, UHS is satisfied that Peacocks Medical Group Limited is satisfying the existing contract to a sufficient standard and will likely satisfy the proposed new contract to a sufficient standard. In making this award decision, UHS assessed the provider against all five PSR key criteria, weighting Quality and Innovation and Integration, Collaboration and Service Sustainability as the highest-priority criteria for maintaining safe interim clinical continuity, followed by Value, Improving Access, Reducing Health Inequalities and Facilitating Choice, and Social Value.